|
DE69634900T2
(de)
*
|
1995-09-11 |
2006-05-18 |
Osteoarthritis Sciences, Inc., Cambridge |
Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
|
|
IL119069A0
(en)
|
1996-08-14 |
1996-11-14 |
Mor Research Applic Ltd |
Pharmaceutical composition comprising tyrphostins
|
|
DE19845372A1
(de)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Verwendung von Katecholderivaten als Proteinaseninhibitoren
|
|
JP2002532493A
(ja)
|
1998-12-17 |
2002-10-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｊｎｋプロテインキナーゼ阻害剤としての４−アリールオキシインドール
|
|
EP1157019B1
(en)
*
|
1998-12-17 |
2003-03-19 |
F. Hoffmann-La Roche Ag |
4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
|
|
BR9916324A
(pt)
|
1998-12-17 |
2001-10-02 |
Hoffmann La Roche |
4,5-pirazinoxindóis como inibidores de proteìna quinase
|
|
US6153634A
(en)
*
|
1998-12-17 |
2000-11-28 |
Hoffmann-La Roche Inc. |
4,5-azolo-oxindoles
|
|
WO2000042213A1
(en)
|
1999-01-13 |
2000-07-20 |
The Research Foundation Of State University Of New York |
A novel method for designing protein kinase inhibitors
|
|
US7070936B1
(en)
|
1999-01-13 |
2006-07-04 |
The Research Foundation Of State University Of New York |
Method for designing protein kinase inhibitors
|
|
EP2322226A3
(en)
*
|
1999-07-21 |
2011-08-17 |
Omeros Corporation |
Solutions and methods for inhibition of pain, inflammation and cartilage degradation
|
|
US6313310B1
(en)
|
1999-12-15 |
2001-11-06 |
Hoffmann-La Roche Inc. |
4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
|
|
EP1875900A3
(en)
*
|
2000-01-24 |
2010-07-21 |
Genzyme Corporation |
JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis
|
|
AU2968701A
(en)
*
|
2000-01-24 |
2001-07-31 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the uses thereof
|
|
US20030152572A1
(en)
*
|
2000-04-06 |
2003-08-14 |
Yoshimi Homma |
Diagnostic and therapeutic agents for rheumatoid arthritis
|
|
US7067550B2
(en)
*
|
2000-11-03 |
2006-06-27 |
Massachusetts Institute Of Technology |
Treatments for neurotoxicity in Alzheimer's Disease
|
|
EP1341548A4
(en)
*
|
2000-11-03 |
2006-06-14 |
Massachusetts Inst Technology |
METHOD FOR IDENTIFYING TREATMENTS AGAINST NEUROTOXICITY IN ALZHEIMER DISEASE CAUSED BY $ g (b) -AMYLOIDPEPTIDE
|
|
US7132427B2
(en)
|
2001-06-21 |
2006-11-07 |
Ariad Pharmaceuticals, Inc. |
Quinazolines and uses thereof
|
|
MXPA04003758A
(es)
*
|
2001-10-22 |
2005-06-20 |
Univ New York State Res Found |
Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
|
|
US7005445B2
(en)
*
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
EP1487434B1
(en)
*
|
2002-03-06 |
2007-05-09 |
The Medical Research and Education Trust |
Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
|
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
|
GB0309850D0
(en)
|
2003-04-30 |
2003-06-04 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2005003765A1
(en)
*
|
2003-06-30 |
2005-01-13 |
Astrazeneca Ab |
Isothermal titration calorimetry assays
|
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2006007664A1
(en)
*
|
2004-07-22 |
2006-01-26 |
Genomics Research Partners Pty Ltd |
Agents and methods for diagnosing osteoarthritis
|
|
US8697139B2
(en)
|
2004-09-21 |
2014-04-15 |
Frank M. Phillips |
Method of intervertebral disc treatment using articular chondrocyte cells
|
|
CN101124228B
(zh)
|
2004-12-14 |
2011-06-15 |
阿斯利康(瑞典)有限公司 |
用作抗肿瘤药物的吡唑并嘧啶化合物
|
|
DE102005005274A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Peter Heger |
Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
|
|
US7820683B2
(en)
|
2005-09-20 |
2010-10-26 |
Astrazeneca Ab |
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer
|
|
JP5137818B2
(ja)
*
|
2006-03-20 |
2013-02-06 |
生化学工業株式会社 |
関節リウマチの処置剤
|
|
US7838542B2
(en)
*
|
2006-06-29 |
2010-11-23 |
Kinex Pharmaceuticals, Llc |
Bicyclic compositions and methods for modulating a kinase cascade
|
|
EP1921070A1
(de)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
|
|
EA200901041A1
(ru)
|
2007-02-06 |
2010-02-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Бициклические гетероциклы, содержащие эти соединения лекарственные средства, их применение и способ их получения
|
|
WO2009026705A1
(en)
*
|
2007-08-24 |
2009-03-05 |
The University Of Western Ontario |
Method of diagnosing and treating osteoarthritis
|
|
RS52573B
(sr)
|
2008-02-07 |
2013-04-30 |
Boehringer Ingelheim International Gmbh |
Spirociklični heterocikli, lekovi koji sadrže navedeno jedinjenje, njihova primena i postupak za njihovu proizvodnju
|
|
BRPI0912170A2
(pt)
|
2008-05-13 |
2015-10-13 |
Astrazeneca Ab |
composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
|
|
CN101396369B
(zh)
*
|
2008-08-07 |
2010-12-01 |
杜宁 |
槐角苷的制药应用
|
|
CA2733153C
(en)
|
2008-08-08 |
2016-11-08 |
Boehringer Ingelheim International Gmbh |
Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
|